Today’s Feature: Teva (TEVA)
Short Float: 1.01%  (no one wants to short this one).
Beta: .19 (low relative volatility) 
Earnings: Next up Feb 14.

03-Nov-10 Reiterated Deutsche Bank Buy $68 → $66
09-Sep-10 Upgrade Oppenheimer Perform → Outperform $65
23-Jul-10 Initiated RBC Capital Mkts Outperform $67
09-Jun-10 Upgrade Collins Stewart Hold → Buy $65
20-May-10 Upgrade Standpoint Research Hold → Buy

Technical Look:
First, the big view  – the weekly.
$50 +- has acted as a pivot point numerous times in the past. It’s not an exact pivot point, but it’s definitely a range.  This, combined with the daily chart gives us a ‘reasonable’ swing entry here to consider.
Second, the daily view:
I like the tightening bollinger bands and the setup for SMA10 to push through SMA20.   MACD has crossed positively and ADX is showing signs of positive momentum.  There is some SMA200 resistance to contend with, but if it can get through, this might be a slow swing through $56, then $65.
I don’t want to hold under $47 and like $51 for swing entry. 



Stock & Option Software used by Bulls on Wallstreet

Social Media

Related Posts

Stop Guessing.
Start Trading.

Secured Checkout Providers

Don’t Miss Out

Pre-Market Live-stream

Tuesday’s and Thursday’s at
9:00 AM EST.

Connect With Us…